Background: A high incidence of venous thromboembolism (VTE) is reported in hospitalized
COVID-19 patients, in particular in patients admitted to the intensive care unit (ICU). In …

Background Colchicine was recently repurposed for the management of coronavirus
disease 2019 (COVID‐19). This rapid review and meta‐analysis aimed to assess …

Abstract Acute Respiratory Distress Syndrome (ARDS) is common in COVID-19 patients and
is associated with high mortality. The aim of this observational study was to describe …

Objectives To review current literature on the role of endothelial dysfunction in coronavirus
disease-2019 (COVID-19) infection in terms of pathophysiology, laboratory features and …

Background COVID-19 has been associated with increased risk of thromboembolism in
critically ill patients. Objective We sought to examine the association of SARS-CoV-2 test …

Background SARS-CoV-2 infections are suspected to trigger the coagulation system through
various pathways leading to a high incidence of thromboembolic complications …

SARS‐CoV‐2 and guttate psoriasis: A case report and review of literature - PMC Back to Top
Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main …

Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the viral
agent responsible for the coronavirus disease of 2019. The disease is primarily a respiratory …

Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) has infected> 235 million
people and killed over 4.8 million individuals worldwide. Although vaccines have been …

BACKGROUND: The predictive value of coagulation markers for venous thromboembolism
(VTE) in COVID-19 patients has been investigated with conflicting results. OBJECTIVE: Our …